Cargando…
Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma
BACKGROUND: Currently, systemic therapies for patients with advanced-stage hepatocellular carcinoma (HCC) rely mainly on systemic drugs. However, traditional systemic drugs have a high rate of serious adverse events, and the curative effects of some potential anticancer drugs, such as curcumin (CUR)...
Autores principales: | Zheng, Yongshun, Jia, Ran, Li, Jun, Tian, Xiaohe, Qian, Yeben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301856/ https://www.ncbi.nlm.nih.gov/pubmed/35858935 http://dx.doi.org/10.1186/s12951-022-01554-y |
Ejemplares similares
-
Association between socioeconomic status and survival in patients with hepatocellular carcinoma
por: Zheng, Yongshun, et al.
Publicado: (2021) -
Synergistic effects of curcumin and bevacizumab on cell signaling pathways in hepatocellular carcinoma
por: GAO, JIAN-ZHI, et al.
Publicado: (2015) -
Curcumin-Loaded Mesoporous Silica Nanoparticles Markedly Enhanced Cytotoxicity in Hepatocellular Carcinoma Cells
por: Kong, Zwe-Ling, et al.
Publicado: (2019) -
Sorafenib-Loaded Cu(2−x)Se Nanoparticles Boost Photothermal–Synergistic Targeted Therapy against Hepatocellular Carcinoma
por: Huang, An-Tian, et al.
Publicado: (2022) -
Synergistic Protective Effect of Curcumin and Resveratrol against Oxidative Stress in Endothelial EAhy926 Cells
por: Zhou, Xian, et al.
Publicado: (2021)